"We found that some cancer types responded extremely well to the immunotherapy, including colon and stomach cancer," ...

Emma Weston joined the clinical trial after running out of treatment options. For two years, she's been cancer free.

Bianca Harvey lived a healthy and athletic lifestyle and was shocked to be diagnosed with colon cancer at 33. Now, she vows ...

Some people with early stage cancers may be able to skip surgery after being treated with the immunotherapy drug dostarlimab, ...

Immunotherapy let some cancer patients with mismatch repair deficient tumors completely avoid surgery, chemo and radiation, a ...

New results from a clinical trial led by Memorial Sloan Kettering Cancer Center (MSK), gastrointestinal oncologists Andrea ...

A New England Journal of Medicine study published April 27 found success in administering dostarlimab, an immunotherapy drug, ...

A Stage 4 cancer survivor is grateful for a 'lifesaving' clinical trial, but experts are wary over potential federal funding ...

Patients with some gastrointestinal tumors were able to be treated with immunotherapy drugs alone and avoid surgery, ...

Bristol Myers Squibb (BMS) has announced that its dual immunotherapy combination has been recommended by the National ...

Bret Hulick was in his second year of medical school at LECOM in Erie, analyzing the case of a 24-year-old colon cancer ...

Neoadjuvant PD-1 blockade with dostarlimab achieved high rates of organ preservation in patients with early-stage mismatch ...